Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jennifer Schenfeld"'
Autor:
Timothy Beukelman, Aimee Lougee, Roland A. Matsouaka, David Collier, Dax G. Rumsey, Jennifer Schenfeld, Scott Stryker, Marinka Twilt, Yukiko Kimura, for the CARRA Registry Investigators
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 19, Iss 1, Pp 1-10 (2021)
Abstract Background We aimed to characterize etanercept (ETN) use in juvenile idiopathic arthritis (JIA) patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. Methods The CARRA Registry is a convenience coh
Externí odkaz:
https://doaj.org/article/d056c24033314e938b2fb3abfb0b215a
Autor:
Reshma Mahtani, Jeffrey Crawford, Sinéad M. Flannery, Tatiana Lawrence, Jennifer Schenfeld, Prasad L. Gawade
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-19 (2021)
Abstract Background Pegfilgrastim, a long-acting granulocyte colony-stimulating factor (G-CSF), is commonly used to prevent febrile neutropenia (FN), a potentially life-threatening complication, following myelosuppressive chemotherapy. The FDA label
Externí odkaz:
https://doaj.org/article/1b326982c9d54f28ab74259e0e246318
Publikováno v:
Journal of Cancer Education.
Bone metastases are common in advanced breast cancer (BC) patients and increase the risk for skeletal-related events (SREs), which present a significant health and economic burden. Bone targeting agents (BTAs) can improve health-related quality of li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::577e9a6b157ec6ea34d9d45975c00f3c
https://doi.org/10.1007/s13187-023-02293-w
https://doi.org/10.1007/s13187-023-02293-w
Autor:
Heather E Stefanski, Stephanie Bo-Subait, Hati Kobusingye, Deborah Mattila, Michelle Kuxhausen, Jennifer Schenfeld, Darcie Sandschafer, Cisio De Oliveira Brandao, Linda J Burns, Bronwen E. Shaw, Michael A. Pulsipher, John P Miller, Steven M Devine
Publikováno v:
Blood. 140:10862-10864
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7544752e59a24a8240413ca9a6501566
https://doi.org/10.1182/blood-2022-159700
https://doi.org/10.1182/blood-2022-159700
Autor:
Jennifer Schenfeld, TingTing Gong, David Henry, Michael Kelsh, Prasad Gawade, Yi Peng, Brian D. Bradbury, Shuling Li
Publikováno v:
Supportive Care in Cancer. 30:6327-6338
Guidelines recommend primary prophylactic (PP) granulocyte colony stimulating factor (G-CSF) for prevention of febrile neutropenia (FN) in patients receiving myelosuppressive chemotherapy with high risk (HR: 20%), or intermediate risk (IR:10-20%) of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a1d7a21e412da7fd3ee9dee562170e
https://doi.org/10.1007/s00520-022-06967-x
https://doi.org/10.1007/s00520-022-06967-x
Autor:
Mark D. Danese, Jennifer Schenfeld, Jaime Shaw, Prasad Gawade, Akhila Balasubramanian, Michael Kelsh, Rohini K. Hernandez, Gary Lyman
Publikováno v:
Advances in Therapy. 39:2778-2795
Patients diagnosed with cancer have an increased risk both for myelodysplastic syndromes (MDS) and for acute myeloid leukemia (AML) following treatment.Using SEER-Medicare data, we selected patients aged 66 years and older who completed systemic ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8590855285250dc7c72cf8e01dbdba7d
https://doi.org/10.1007/s12325-022-02141-1
https://doi.org/10.1007/s12325-022-02141-1
Autor:
Benoit Cadieux, Guy Boike, Kimberly Lowe, David C Fuehrer, Darcy R. Flora, Katherine B Carlson, Jennifer Schenfeld
Publikováno v:
Cancer Management and Research
Darcy R Flora,1 Katherine B Carlson,2 David C Fuehrer,1 Benoit Cadieux,3 Guy Boike,4 Jennifer Schenfeld,2 Kimberly A Lowe2 1GRYT Health Inc., Rochester, NY, USA; 2Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA; 3Global Medical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bda3780bd5fce4becebdae99d1ef4e2f
http://europepmc.org/articles/PMC8079256
http://europepmc.org/articles/PMC8079256
Publikováno v:
Pediatric Dermatology
Background/Objective Compared with the adult psoriasis population, knowledge about the incidence of comorbidities in the pediatric psoriasis population is limited. The objective of this study was to assess the prevalence and incidence of comorbiditie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::163add3cadba23326402206a1d7e9f14
https://doi.org/10.1111/pde.13772
https://doi.org/10.1111/pde.13772
Autor:
Prasad L. Gawade, Reshma Mahtani, Jeffrey Crawford, Tatiana Lawrence, Jennifer Schenfeld, Sinéad M. Flannery
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-19 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-19 (2021)
Background Pegfilgrastim, a long-acting granulocyte colony-stimulating factor (G-CSF), is commonly used to prevent febrile neutropenia (FN), a potentially life-threatening complication, following myelosuppressive chemotherapy. The FDA label for pegfi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f84dfd9864fa3832c13b9d3ee9eea5c
https://pubmed.ncbi.nlm.nih.gov/34044798
https://pubmed.ncbi.nlm.nih.gov/34044798
Autor:
Corina W Bennett, Prasad L. Gawade, Renee R Jaramillo, Lucy DeCosta, Jennifer Schenfeld, Shuling Li
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(1)
Purpose Describe temporal changes in use of myelosuppressive chemotherapy, primary prophylactic colony-stimulating factor, and neutropenia-related hospitalization, in commercially insured patients. Methods Using a large commercial administrative data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a70d98671a546161df894e53577a0bb7
https://pubmed.ncbi.nlm.nih.gov/32524908
https://pubmed.ncbi.nlm.nih.gov/32524908